OncoImmune nets $56m Series B
OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding.
OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination